Table 2 Patient characteristics
| Â | No. patients (%) |
|---|---|
| Â | (N=49) |
Age (years) | |
 Median | 50 |
 Range | 28–65 |
Male : female ratio | 27:22 |
Histology at diagnosis (WHO) | |
 Follicular grade 1 | 27 (55) |
 Follicular grade 2 | 22 (45) |
Histologic transformation at ASCT | 22 (45) |
No. failed therapies | |
 0 | 5 (10) |
 1 | 24 (49) |
 2 | 11 (22) |
 3 or more | 9 (18) |
Prior treatment | |
 Anthracycline | 37 (76) |
 Rituximab | 10 (20) |
 Fludarabine | 6 (12) |
Response prior to ASCT | |
 Chemosensitive | 44 (90) |
CR | 20 (41) |
<CR | 24 (49) |
 Chemoresistant | 5 (10) |
